Vice President and Executive Director Xie Xin increased his stake in China Biologic Products (01177.HK) by 1 million shares, with each share priced at approximately 6.41 Hong Kong dollars.

According to the latest information from the Wisdom Financial APP, Hong Kong Stock Exchange, on December 24th, Vice President and Executive Director Xie Xin increased his holdings of China Biotech Pharmaceuticals (01177.HK) by 1 million shares, with a price of 6.4068 Hong Kong dollars per share, totaling 6.4068 million Hong Kong dollars. The latest number of shares held after the increase is approximately 361 million shares, with a latest shareholding ratio of 1.92%.